317 related articles for article (PubMed ID: 16957516)
1. Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis.
Bonderup OK; Hansen JB; Madsen P; Vestergaard V; Fallingborg J; Teglbjaerg PS
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1095-9. PubMed ID: 16957516
[TBL] [Abstract][Full Text] [Related]
2. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment.
Münch A; Söderholm JD; Ost A; Ström M
Am J Gastroenterol; 2009 Mar; 104(3):679-85. PubMed ID: 19209166
[TBL] [Abstract][Full Text] [Related]
3. Expression of inducible nitric oxide synthase and effects of L-arginine on colonic nitric oxide production and fluid transport in patients with "minimal colitis".
Perner A; Andresen L; Normark M; Fischer-Hansen B; Rask-Madsen J
Scand J Gastroenterol; 2005 Sep; 40(9):1042-8. PubMed ID: 16165717
[TBL] [Abstract][Full Text] [Related]
4. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population.
Gupta SK; Fitzgerald JF; Chong SK; Croffie JM; Garcia JG
Am J Gastroenterol; 1998 May; 93(5):795-8. PubMed ID: 9625130
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: budesonide treatment for collagenous colitis.
Feyen B; Wall GC; Finnerty EP; DeWitt JE; Reyes RS
Aliment Pharmacol Ther; 2004 Oct; 20(7):745-9. PubMed ID: 15379834
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and vascular endothelial growth factor in esophageal mucosa biopsy specimens from patients with reflux esophagitis.
Inamori M; Shimamura T; Nagase H; Abe Y; Umezawa T; Nakajima A; Saito T; Ueno N; Tanaka K; Sekihara H; Togawa J; Kaifu H; Tsuboi H; Kayama H; Tominaga S
Hepatogastroenterology; 2006; 53(69):361-5. PubMed ID: 16795973
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide.
Miehlke S; Madisch A; Voss C; Morgner A; Heymer P; Kuhlisch E; Bethke B; Stolte M
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1115-9. PubMed ID: 16305725
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epithelium.
Kolios G; Manousou P; Bourikas L; Notas G; Tsagarakis N; Mouzas I; Kouroumalis E
Eur J Clin Invest; 2006 Oct; 36(10):720-9. PubMed ID: 16968468
[TBL] [Abstract][Full Text] [Related]
9. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis.
Koskela LR; Thiel T; Ehrén I; De Verdier PJ; Wiklund NP
J Urol; 2008 Aug; 180(2):737-41. PubMed ID: 18554637
[TBL] [Abstract][Full Text] [Related]
10. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile.
Tagkalidis PP; Gibson PR; Bhathal PS
J Clin Pathol; 2007 Apr; 60(4):382-7. PubMed ID: 16775121
[TBL] [Abstract][Full Text] [Related]
11. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
[TBL] [Abstract][Full Text] [Related]
12. Budesonide for the treatment of collagenous colitis: first results of a pilot trial.
Tromm A; Griga T; Möllmann HW; May B; Müller KM; Fisseler-Eckhoff A
Am J Gastroenterol; 1999 Jul; 94(7):1871-5. PubMed ID: 10406251
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
[TBL] [Abstract][Full Text] [Related]
14. Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis.
Menchén L; Colón AL; Madrigal JL; Beltrán L; Botella S; Lizasoain I; Leza JC; Moro MA; Menchén P; Cos E; Lorenzo P
Am J Gastroenterol; 2004 Sep; 99(9):1756-64. PubMed ID: 15330915
[TBL] [Abstract][Full Text] [Related]
15. Colonic mucosal tears in collagenous colitis.
Wickbom A; Lindqvist M; Bohr J; Ung KA; Bergman J; Eriksson S; Tysk C
Scand J Gastroenterol; 2006 Jun; 41(6):726-9. PubMed ID: 16716973
[TBL] [Abstract][Full Text] [Related]
16. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein.
Cirillo C; Sarnelli G; Esposito G; Grosso M; Petruzzelli R; Izzo P; Calì G; D'Armiento FP; Rocco A; Nardone G; Iuvone T; Steardo L; Cuomo R
Neurogastroenterol Motil; 2009 Nov; 21(11):1209-e112. PubMed ID: 19558426
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves.
Konturek PC; Brzozowski T; Engel M; Burnat G; Gaca P; Kwiecien S; Pajdo R; Konturek SJ
J Physiol Pharmacol; 2009 Jun; 60(2):41-7. PubMed ID: 19617644
[TBL] [Abstract][Full Text] [Related]
18. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey.
Ribbons KA; Currie MG; Connor JR; Manning PT; Allen PC; Didier P; Ratterree MS; Clark DA; Miller MJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):1008-15. PubMed ID: 9023318
[TBL] [Abstract][Full Text] [Related]
19. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis.
Bonderup OK; Hansen JB; Birket-Smith L; Vestergaard V; Teglbjaerg PS; Fallingborg J
Gut; 2003 Feb; 52(2):248-51. PubMed ID: 12524408
[TBL] [Abstract][Full Text] [Related]
20. Anorectal function in patients with collagenous colitis in active and clinically quiescent phase, in comparison with healthy controls.
Walter SA; Münch A; Ost A; Ström M
Neurogastroenterol Motil; 2010 May; 22(5):534-8, e118. PubMed ID: 20156310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
